Citation Tools

Download PDFPDF

Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial

Download to a citation manager

Cite this article as:
Seibold JR, Maher TM, Highland KB on behalf of the SENSCIS trial investigators, et al
Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial